Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (26)

2021

  1. Effects of mesoporous SiO2-CaO nanospheres on the murine peritoneal macrophages/Candida albicans interface

    International Immunopharmacology, Vol. 94

2020

  1. An immunological approach to the biocompatibility of mesoporous sio2-cao nanospheres

    International Journal of Molecular Sciences, Vol. 21, Núm. 21, pp. 1-21

2019

  1. Characterization of M1 and M2 polarization phenotypes in peritoneal macrophages after treatment with graphene oxide nanosheets

    Colloids and Surfaces B: Biointerfaces, Vol. 176, pp. 96-105

2018

  1. Differential effects of graphene oxide nanosheets on Candida albicans phagocytosis by murine peritoneal macrophages

    Journal of Colloid and Interface Science, Vol. 512, pp. 665-673

  2. Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 250-259

2016

  1. Effects of nanocrystalline hydroxyapatites on macrophage polarization

    Journal of Materials Chemistry B, Vol. 4, Núm. 11, pp. 1951-1959

2014

  1. Early in vitro response of macrophages and T lymphocytes to nanocrystalline hydroxyapatites

    Journal of Colloid and Interface Science, Vol. 416, pp. 59-66

  2. In vitro evaluation of graphene oxide nanosheets on immune function

    Journal of Colloid and Interface Science, Vol. 432, pp. 221-228

2012

  1. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells

    Acta Biomaterialia, Vol. 8, Núm. 7, pp. 2770-2777

  2. Signaling Pathways of Immobilized FGF-2 on Silicon-Substituted Hydroxyapatite

    Macromolecular Bioscience, Vol. 12, Núm. 4, pp. 446-453

2011

  1. Immobilization and bioactivity evaluation of FGF-1 and FGF-2 on powdered silicon-doped hydroxyapatite and their scaffolds for bone tissue engineering

    Journal of Materials Science: Materials in Medicine, Vol. 22, Núm. 2, pp. 405-416

  2. Strategy for fluorescent labeling of human acidic fibroblast growth factor without impairment of mitogenic activity: A bona fide tracer

    Analytical Biochemistry, Vol. 411, Núm. 1, pp. 1-9

2009

  1. N-terminal negatively charged residues in CD3ε chains as a phylogenetically conserved trait potentially yielding isoforms with different isoelectric points: Analysis of human CD3ε chains

    Immunology Letters, Vol. 126, Núm. 1-2, pp. 8-15

2007

  1. Loss of N-terminal charged residues of mouse CD3ε chains generates isoforms modulating antigen T cell receptor-mediated signals and T cell receptor-CD3 interactions

    Journal of Biological Chemistry, Vol. 282, Núm. 31, pp. 22324-22334

  2. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: Binding to M type 18 strains is independent of Emm or Enn proteins

    Molecular Immunology, Vol. 44, Núm. 14, pp. 3571-3579

2006

  1. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli

    Journal of Immunology, Vol. 177, Núm. 4, pp. 2543-2551

2004

  1. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes

    European Journal of Immunology, Vol. 34, Núm. 9, pp. 2439-2448

2003

  1. Mechanisms of H4/ICOS costimulation: Effects on proximal TCR signals and MAP kinase pathways

    European Journal of Immunology, Vol. 33, Núm. 1, pp. 204-214

2002

  1. The TCR/CD3 complex: Molecular interactions in a changing structure

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 50, Núm. 4, pp. 263-272

2000

  1. Variability of invariant mouse CD3ε chains detected by anti-CD3 antibodies

    European Journal of Immunology, Vol. 30, Núm. 5, pp. 1469-1479